Skip to main content

Bruker, Kiestra Ink Co-marketing Pact for Microbiology Mass Spec System

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Bruker Daltonics and Kiestra Lab Automation said today that they have expanded a co-marketing and cross-selling partnership covering the use of their technologies in microbiology laboratories.

The companies have also signed a research and development agreement to integrate Bruker's MALDI Biotyper and Kiestra’s MalditofA, an automatic colony picker.

The MALDI Biotyper classifies microorganisms through proteomic fingerprinting via high-throughput MALDI-TOF mass spectrometry while the MalditofA is used to automatically transfer a colony to the target plate in order to prevent mismatches.

"Each of our technologies alone has been quite successful already, and in combination they could change the way microbiology is performed in many routine labs," said Wolfgang Pusch, vice president for clinical research solutions and in vitro diagnostics at Bruker Daltonics. "Both technologies integrated together will help microbiology laboratories to perform their important tasks faster and better, despite a predicted shortage in experienced laboratory staff."

The Scan

WHO OKs Emergency Use of Sinopharm Vaccine

The World Health Organization has granted emergency approval for Sinopharm's SARS-CoV-2 vaccine, the Guardian reports.

Scientific Integrity Panel to Meet

According to the Associated Press, a new US scientific integrity panel is to meet later this week.

Trying in the Eye

NPR reports that a study of Editas Medicine's CRISPR therapy for Leber congenital amaurosis has begun.

PLOS Papers on Cerebellum Epigenetics, Copy Number Signature Tool, Acute Lung Injury Networks

In PLOS this week: epigenetics analysis of brain tissue, bioinformatics tool to find copy number signatures in cancer, and more.